Hemodynamic characteristics of hypertrophic and congestive cardiomyopathies

Insights

Hypertrophic cardiomyopathy (HCM) shows normal contractility but increased chamber stiffness, while congestive cardiomyopathy (CCM) exhibits reduced contractility and elevated muscle stiffness, especially with heart failure.

Area of Science:

  • Cardiology
  • Physiology
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) and congestive cardiomyopathy (CCM) present distinct hemodynamic and mechanical challenges.
  • Understanding myocardial properties is crucial for differentiating these conditions and guiding treatment.

Purpose of the Study:

  • To compare the hemodynamics and mechanical properties of the myocardium in patients with HCM, CCM, and healthy individuals.
  • To elucidate the underlying mechanisms contributing to cardiac dysfunction in HCM and CCM.

Main Methods:

  • Evaluated preload, afterload, contractility, relaxation, compliance, and performance in 19 HCM patients, 11 CCM patients, and 15 controls.
  • Utilized parameters such as peak positive dp/dt, ejection fraction, time constant T, elastic stiffness constant, and left ventricular minute work.

Main Results:

  • HCM showed normal contractility indices but elevated chamber stiffness; CCM displayed markedly reduced contractility and increased muscle stiffness with heart failure.
  • Afterload was reduced in HCM, while preload was elevated in CCM with heart failure.
  • Relaxation abnormalities were present in both HCM and CCM.

Conclusions:

  • CCM's primary issue is contractile failure, associated with elevated preload and muscle stiffness during heart failure.
  • HCM's reduced unit muscle contractility, despite normal conventional indices, suggests hypertrophy is a compensatory mechanism.
  • Chamber stiffness is significantly elevated in HCM, while unit muscle stiffness increases in CCM with heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...